BioNTech SE (22UA)
FSX
Closed
Aug 21, 2026
Day's Range
93.9052 wk Range
68.00Overview - 22UA - BioNTech SE
Key Statistics
Valuation
Enterprise Value
10.62B
P/E (Trailing)
‪157.87‬
P/E (Forward)
‪2.29‬
PEG Ratio
‪1.54‬
Price / Sales (TTM)
‪9.58‬
Price / Book
‪1.43‬
EV / EBITDA
‪-7.69‬
Profitability
Gross Margin
‪8.14%‬
Profit Margin
‪-63.63%‬
Operating Margin
‪-806.62%‬
Return on Assets
‪-5.41%‬
Return on Equity
‪-9.30%‬
Ownership
Shares Outstanding
251.20M
Float
108.41M
Held by Insiders
‪57.51%‬
Held by Institutions
‪20.37%‬
Price stats
Beta
‪1.27‬
50-Day Avg
‪80.49‬
200-Day Avg
‪83.46‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 22UA - BioNTech SE
Peers - 22UA - BioNTech SE
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- 22UAFSXBioNTech SE23.77BMarket Cap-1.00%52-week change157.87P/E (Trailing)‪-63.63%‬Profit Margin
- ANLFSXAnalog Devices, Inc.155.74BMarket Cap+33.03%52-week change44.38P/E (Trailing)‪29.78%‬Profit Margin
- 1AEFSXargenx SE54.66BMarket Cap+32.95%52-week change39.15P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt54.41BMarket Cap+34.86%52-week change38.91P/E (Trailing)‪32.26%‬Profit Margin
- 0QFFSXModerna, Inc.50.02BMarket Cap+82.32%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 42ZFSXRevolution Medicines Inc.38.84BMarket Cap+82.79%52-week change-30.46P/E (Trailing)‪0.00%‬Profit Margin
- 49BAFSXBeOne Medicines, Ltd. American Depositary Receipt35.97BMarket Cap+14.46%52-week change65.56P/E (Trailing)‪10.69%‬Profit Margin
Profile Summary - 22UA - BioNTech SE
About
BioNTech SE is a biotechnology company focused on the development of immunotherapies and mRNA-based medicines for cancer and infectious diseases. The company’s current portfolio includes oncology programs such as personalized and off-the-shelf cancer immunotherapies, cell therapies, and targeted biologic approaches…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
